An overview on the national burden of tuberculosis and its current status

Abstract

Tuberculosis (TB) still remain a major challenging global health problem. India is one the high TB burden country, adding to 26 per cent of the worldwide TB burden. During the 20th century, TB became treatable and the therapeutic success of short-course chemotherapy was a break through. In the early 1980s, human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS) pandemic resulted in a resurgence of TB globally with more complications and challenges like occurrence of multidrug-resistant and extensively drug-resistant TB (M/XDR-TB). Atypical clinical presentation still poses a challenge. While treatment of TB and HIV-TB co-infection has become simpler, efforts are on to shorten the treatment duration. However, drug toxicities, adverse drug reactions and drug-drug interactions still possess a significant challenge. Hurdles like the lack of adequate coverage, low economy and weak health services limit access to high-quality tuberculosis care in some of the countries. Further, many public and private health-care providers remain delinked from national tuberculosis control efforts. In addition, tuberculosis is a disease of the poor and the absence of universal health coverage aggravates the economic burden of TB on the poor. Even though the advancements in tuberculosis control over the past two decades are strong, relatively high effort is needed to wipe out the pandemic. A pursuit for novel biomarkers for predicting a durable cure, relapse, discovery/repurposing of newer anti-TB drugs, development of newer vaccines continues to attain the goal of eliminating TB altogether by 2050. The present review focuses on the global and Indian tuberculosis situation. It emphasizes the epidemiological situation in India and the burden of disease in the nation over time.

Authors and Affiliations

Keerthy J

Keywords

Related Articles

In vitro studies on phytochemical analysis and antioxidant activity of Manilkara zapota

Sapota is one of the prominent fruits and belongs to family sapotaceae. India is the largest producer of sapota. In this present study, phytochemicals were analysed and antioxidant activity was determined for sapota frui...

Comparing the adverse drug reactions of conventional versus newer anti epileptic drugs: an observational study

Introduction Neurological disorders have been estimated to account for up to 20% of the nationwide cost of healthcare in developed countries. There is growing concern to assess the Adverse Drug Reactions (ADRs) of anti-...

Quality by design approach to analytical method development for simultaneous estimation of ibuprofen and famotidine in their combined dosage form by RP-HPLC method

This article aims to explain the steps for application of quality by design (QbD) concept to analytical method development and validation, by using an example of simultaneous determination of Famotidine and Ibuprofen in...

Awareness of pregnant women about folic acid supplementation during pregnancy to reduce neural tube defects

Aim The aim of the study was to measure awareness of pregnant women about folic acid supplementation during pregnancy to reduce neural tube defects. Methods A prospective observational cross sectional study was conducte...

Anti-inflammatory activity of Avicennia officinalis in methanolic extract

The Aim of this study is to examine the anti-inflammatory activity of Avicennia officinalis. The anti- inflammatory activity was estimated by carrageenan-induced acute, formalin-induced sub-acute paw edema, Freud’s comp...

Download PDF file
  • EP ID EP411010
  • DOI -
  • Views 112
  • Downloads 0

How To Cite

Keerthy J (2015). An overview on the national burden of tuberculosis and its current status. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 4(4), 428-434. https://europub.co.uk/articles/-A-411010